help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuruta, E.
Right arrow Articles by Amino, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuruta, E.
Right arrow Articles by Amino, N.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 350-355, Copyright © 1995 by Endocrine Society


ARTICLES

Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis

E Tsuruta, H Tada, H Tamaki, T Kashiwai, K Asahi, K Takeoka, N Mitsuda and N Amino
Department of Laboratory Medicine, Osaka University Medical School, Japan.

We reported that gestational thyrotoxicosis is induced by thyroid- stimulating activity (TSA) of circulating hCG. However, the serum immunological hCG concentration did not correlate to TSA. To elucidate this, we examined the relation of carbohydrate moieties of hCG to bioactivity in 79 early pregnant women, divided into 4 groups: no emesis, mild emesis, hyperemesis, and gestational thyrotoxicosis with hyperemesis. Serum free T4 (FT4) and free T3 (FT3) levels were significantly higher and TSH was lower in the hyperemesis (FT4, 23.42 +/- 5.02 pmol/L; FT3, 6.26 +/- 1.80 pmol/L; TSH, 0.30 +/- 0.44 mU/L) and in gestational thyrotoxicosis (FT4, 48.65 +/- 14.80 pmol/L; FT3, 14.71 +/- 3.47 pmol/L; TSH, < 0.04 mU/L) groups than in the no emesis group (FT4, 16.99 +/- 2.48 pmol/L; FT3, 5.51 +/- 0.75 pmol/L; TSH, 1.37 +/- 1.23 mU/L; P < 0.0005). TSA was also significantly higher in the hyperemesis (566 +/- 187%) and gestational thyrotoxicosis (832 +/- 168%) groups than in the no emesis group (321 +/- 135%). We found no significant difference among serum hCG concentrations measured by immunoassay in the four groups. To characterize the carbohydrate chains, serum hCG was fractionated by Concanavalin-A and ricin lectin affinity chromatography. The fraction firmly bound to Con-canavalin-A, which contains hCG with high mannose and hybrid-type carbohydrate chains, was significantly higher in the hyperemesis group (91.07 +/- 2.06%; n = 15) than in the no emesis group (89.61 +/- 2.38%; n = 24; P < 0.04). The fraction firmly bound to ricin column, which contains hCG with asialo-carbohydrate chains, was significantly increased in the gestational thyrotoxicosis group (3.44 +/- 1.70%; n = 5) compared with that in the no emesis group (1.77 +/- 0.49%; n = 24; P < 0.03). Serum FT4 positively correlated to the hCG fraction firmly bound to ricin column (r = 0.61; P < 0.001). We conclude that thyrotoxicosis with hyperemesis may be caused by circulating asialo-hCG with higher thyrotropic bioactivity.


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
M.F.G. Verberg, D.J. Gillott, N. Al-Fardan, and J.G. Grudzinskas
Hyperemesis gravidarum, a literature review
Hum. Reprod. Update, September 1, 2005; 11(5): 527 - 539.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Rodien, N. Jordan, A. Lefevre, J. Royer, C. Vasseur, F. Savagner, A. Bourdelot, and V. Rohmer
Abnormal stimulation of the thyrotrophin receptor during gestation
Hum. Reprod. Update, March 1, 2004; 10(2): 95 - 105.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Amino, H. Tada, Y. Hidaka, and Y. Izumi
Thyroid Function during Pregnancy
Clin. Chem., July 1, 2000; 46(7): 1015 - 1016.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. A. KOUTRAS
Thyroidopathies
Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 77 - 88.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. Rodien, C. Bremont, M.-L. R. Sanson, J. Parma, J. Van Sande, S. Costagliola, J.-P. Luton, G. Vassart, and L. Duprez
Familial Gestational Hyperthyroidism Caused by a Mutant Thyrotropin Receptor Hypersensitive to Human Chorionic Gonadotropin
N. Engl. J. Med., December 17, 1998; 339(25): 1823 - 1826.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. S. Liberman, S. C. Pino, S. L. Fang, L. E. Braverman, and C. H. Emerson
Circulating Iodide Concentrations during and after Pregnancy
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3545 - 3549.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
D. Glinoer
The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology
Endocr. Rev., June 1, 1997; 18(3): 404 - 433.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society